Democratic Republic of the Congo vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology

Democratic Republic of the Congo
1.4%
in 2024
Syrian Arab Republic
2.9%
in 2024
Democratic Republic of the Congo rank
22nd
Syrian Arab Republic rank
6th

Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time

  • Democratic Republic of the Congo
  • Syrian Arab Republic
1234201520192024

How they compare

Syrian Arab Republic currently reports 2.9% against 1.4% in Democratic Republic of the Congo, a difference of 1.5%.

That makes Syrian Arab Republic's figure about 2.1 times Democratic Republic of the Congo's.

Across all 10 years both countries report, Syrian Arab Republic has been ahead every year.

Democratic Republic of the Congo ranks 22nd and Syrian Arab Republic ranks 6th of 246 countries.

Syrian Arab Republic has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Democratic Republic of the Congo Syrian Arab Republic Difference Ahead
2010s 1.5% 3.5% 2.0% Syrian Arab Republic
2020s 1.4% 3.4% 2.0% Syrian Arab Republic

Averages of every year both report within each decade.

Frequently asked questions

Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Democratic Republic of the Congo or Syrian Arab Republic?
Syrian Arab Republic, at 2.9% against 1.4% in Democratic Republic of the Congo as of 2024.
What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Democratic Republic of the Congo and Syrian Arab Republic?
1.5%, with Syrian Arab Republic ahead.
How many years of comparable data are there for Democratic Republic of the Congo and Syrian Arab Republic?
10 years are reported by both, from 2015 to 2024.
How do Democratic Republic of the Congo and Syrian Arab Republic rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
Democratic Republic of the Congo ranks 22nd and Syrian Arab Republic ranks 6th of 246 countries.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Democratic Republic of the Congo vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 14 September 2026, from https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/democratic-republic-of-the-congo/syrian-arab-republic-2/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/prevalence-of-hepatitis-b-surface-antigen-hbsag-2026-methodology-percent/democratic-republic-of-the-congo/syrian-arab-republic-2/">Democratic Republic of the Congo vs Syrian Arab Republic: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology</a> — Statizoid

About this data

Indicator
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
250 places, 2,500 data points, 2015–2024
Last refreshed